Fenofibrate and Immunodeficiency disorders - a phase IV clinical study of FDA data

Summary:

Immunodeficiency disorders is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are male, 60+ old, also take Amlodipine, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Immunodeficiency disorders when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Immunodeficiency disorders?

Immunodeficiency disorders is found to be associated with 705 drugs and 942 conditions by eHealthMe. Check the latest studies of Immunodeficiency disorders.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 13 people (0.03%) have Immunodeficiency disorders.

Could Fenofibrate cause Immunodeficiency disorders?

Among these 13 people:

What is the gender of people who have Immunodeficiency disorders when taking Fenofibrate? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Immunodeficiency disorders when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Immunodeficiency disorders? *

Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
Haemoglobin Decreased: 2 people, 15.38%
Anaemia (lack of blood): 2 people, 15.38%
Hypersensitivity: 2 people, 15.38%
Rhinovirus Infection: 2 people, 15.38%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 2 people, 15.38%
Fever: 2 people, 15.38%
Enterovirus Infection: 2 people, 15.38%
Urinary Tract Infection: 1 person, 7.69%
Enterococcal Sepsis: 1 person, 7.69%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 23.08%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 15.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
Pain: 2 people, 15.38%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Blood Triglycerides Decreased: 1 person, 7.69%
Cellulitis (infection under the skin): 1 person, 7.69%
Depression: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Immunodeficiency disorders?

- Check whether Immunodeficiency disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,457 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (705 drugs)

Browse all the conditions that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (942 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.